These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 37308716)

  • 1. Insights into recent findings and clinical application of YAP and TAZ in cancer.
    Franklin JM; Wu Z; Guan KL
    Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities.
    Garcia K; Gingras AC; Harvey KF; Tanas MR
    Trends Cancer; 2022 Dec; 8(12):1033-1045. PubMed ID: 36096997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo Pathway in Prostate Cancer.
    Salem O; Hansen CG
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of YAP/TAZ in ferroptosis.
    Magesh S; Cai D
    Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation.
    Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S
    Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
    Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
    Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ at the Roots of Cancer.
    Zanconato F; Cordenonsi M; Piccolo S
    Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.
    Luo J; Zou H; Guo Y; Tong T; Chen Y; Xiao Y; Pan Y; Li P
    Br J Cancer; 2023 May; 128(9):1611-1624. PubMed ID: 36759723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of myocardial glucose metabolism by YAP/TAZ signaling.
    Kashihara T; Sadoshima J
    J Cardiol; 2024 May; 83(5):323-329. PubMed ID: 38266816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
    Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
    J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.
    Kim MH; Kim J
    Cell Mol Life Sci; 2017 Apr; 74(8):1457-1474. PubMed ID: 27826640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers.
    Howard A; Bojko J; Flynn B; Bowen S; Jungwirth U; Walko G
    Exp Dermatol; 2022 Oct; 31(10):1477-1499. PubMed ID: 35913427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
    Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
    J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
    Wang Y; Chen H; Yu J; Kang W; To KF
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.
    Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS
    Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.